Back to browse

EXP002558

Paper

Peptide-Based Nanoparticles to Rapidly and Efficiently “Wrap ’n Roll” siRNA into Cells (2019)

Peptide

WRAP4

Sequence: LLRLLRWWRLLRLL

RNA

siRNA

All experiment fields

Experiment Id EXP002558
Paper Peptide-Based Nanoparticles to Rapidly and Efficiently “Wrap ’n Roll” siRNA into Cells
Peptide WRAP4
Delivery Success Class no
In Vivo Flag no
Uptake Confirmed no
Label Confidence medium
In Vitro Functional Effect yes
Endosomal Escape Evidence
Peptide Concentration Peptide concentration varied by molar ratio; 400 nM peptide at R=20 with 20 nM siRNA in main cellular assays
Rna Concentration 20 nM siRNA in main reporter screen; dose-response tested 1–20 nM for lead peptides
Mixing Ratio R = 20 peptide:siRNA molar ratio for main experiments
Formulation Format noncovalent peptide-based nanoparticle
Formulation Components WRAP4 mixed with siRNA in 5% glucose aqueous solution; nanoparticle formation by one-step electrostatic/hydrophobic complexation
Size Nm 193.50
Zeta Mv
Model Scope in_vitro
Model Type in vitro reporter/target-gene knockdown
Cell Lines Or Primary Cells U87 glioblastoma reporter cells; additional cell lines tested for WRAP1/WRAP5 where applicable
Animal Model
Administration Route in vitro transfection
Output Type luciferase reporter knockdown
Output Value Variable luciferase knockdown mainly at R=40; excluded from further development.
Output Units
Output Notes Initial WRAP screen using U87 cells stably expressing firefly/NanoLuc reporters; peptide-only and siRNA-only controls did not induce silencing.
Toxicity Notes LDH assay indicated no relevant cytotoxicity for active WRAP/siRNA nanoparticle conditions; RNAiMAX caused ~20% cytotoxicity in the comparison assay.
Curation Notes